LVOQX
Price
$17.28
Change
-$0.16 (-0.92%)
Updated
Oct 9 closing price
Net Assets
1.13B
VEXAX
Price
$160.46
Change
-$0.96 (-0.59%)
Updated
Oct 9 closing price
Net Assets
83.66B
Interact to see
Advertisement

LVOQX vs VEXAX

Header iconLVOQX vs VEXAX Comparison
Open Charts LVOQX vs VEXAXBanner chart's image
Lord Abbett Value Opportunities R2
Price$17.28
Change-$0.16 (-0.92%)
VolumeN/A
Net Assets1.13B
Vanguard Extended Market Index Admiral
Price$160.46
Change-$0.96 (-0.59%)
VolumeN/A
Net Assets83.66B
LVOQX vs VEXAX Comparison Chart in %
View a ticker or compare two or three
VS
LVOQX vs. VEXAX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVOQX is a Buy and VEXAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 83.7B vs. LVOQX (1.13B). VEXAX pays higher dividends than LVOQX: VEXAX (1.10) vs LVOQX (0.00). LVOQX was incepted earlier than VEXAX: LVOQX (18 years) vs VEXAX (25 years). LVOQX (1.54) is less costly to investors than VEXAX (0.05). LVOQX is a more actively managed with annual turnover of: 33.00 vs. VEXAX (11.00). LVOQX has a lower initial minimum investment than VEXAX: LVOQX (0) vs VEXAX (3000). VEXAX annual gain was more profitable for investors over the last year : 17.37 vs. LVOQX (-7.04). VEXAX return over 5 years is better than : 55.22 vs. LVOQX (3.26).
LVOQXVEXAXLVOQX / VEXAX
Total Expense Ratio1.540.053,080%
Annual Report Gross Expense Ratio1.540.053,080%
Fund Existence18 years25 years-
Gain YTD0.46112.2754%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.13B83.7B1%
Annual Yield % from dividends0.001.10-
Returns for 1 year-7.0417.37-41%
Returns for 3 years17.3666.6526%
Returns for 5 years3.2655.226%
Returns for 10 years-8.85156.96-6%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEPG5.030.16
+3.29%
PepGen
IPSC0.600.01
+2.31%
Century Therapeutics
LOAR79.400.38
+0.48%
Loar Holdings
AZTA31.73-0.50
-1.55%
Azenta
AAPL254.04-4.02
-1.56%
Apple